...
机译:一块谜题:围手术期偶甲酸甲酸期间FVIII的人口药代动力学? 还 /哼唱P? 还 冯维尔布朗疾病病患者的治疗
Hospital Pharmacy ‐ Clinical PharmacologyUniversity of AmsterdamAmsterdam The Netherlands;
Hospital Pharmacy ‐ Clinical PharmacologyUniversity of AmsterdamAmsterdam The Netherlands;
Department of Paediatric HematologyErasmus University Medical Center – Sophia Children's;
Department of Paediatric HematologyErasmus University Medical Center – Sophia Children's;
Amsterdam UMCUniversity of AmsterdamAmsterdam Netherlands;
Department of HaematologyUniversity Medical Center GroningenGroningen The Netherlands;
Department of Internal MedicineLeiden University Medical CenterLeiden The Netherlands;
Department of HaematologyRadboud University Medical CenterNijmegen The Netherlands;
Department of HematologyErasmus University Medical CenterRotterdam The Netherlands;
Department of Paediatric HematologyErasmus University Medical Center – Sophia Children's;
Hospital Pharmacy ‐ Clinical PharmacologyUniversity of AmsterdamAmsterdam The Netherlands;
Haemate P; individualized medicine; pharmacokinetics; surgery; von Willebrand disease;
机译:一块谜题:围手术期偶甲酸甲酸期间FVIII的人口药代动力学? 还 /哼唱P? 还 冯维尔布朗疾病病患者的治疗
机译:VIII因子/ von Willebrand因子浓缩物haemate-P / humate-P的功效和安全性:von Willebrand病患者的ristocetin辅因子单位给药。
机译:血浆衍生的VWF / FVIII浓缩物(迁移率为von Willebrand疾病患者的按需和预防治疗的药代动力学,疗效和安全性(SWIFT-VWD研究)
机译:von Willebrand疾病患者的术前DDAVP测试
机译:外科手术中的技术性能和患者结果:另一个难题
机译:血浆源性VWF / FVIII浓缩物(VONCENTO)在von Willebrand病患者中按需和预防性治疗的药代动力学功效和安全性(SWIFT-VWD研究)
机译:HAEMATEP®根治性药物治疗严重Von WILLEBRAND病患者出血的PSY24成本效益